Skip to content

Legacy Giving: Support OCRA Through an Estate Plan

Estate Planning

Create a lasting legacy to fund future research and support programs by donating to The Teal Trust.

Ensure a Life-Saving Legacy

Including OCRA in your estate plan is an easy way to commit to funding crucial research for ovarian and related gynecologic cancers now and in the future.

Your lawyer or financial advisor can assist with either creating or adjusting your estate plans.

We recommend that your bequest be designated for unrestricted purposes or be directed to general research because we cannot predict future medical advances or the future of our patient support programs.

Need help creating an estate plan?

FreeWill, a secure online resource that we have partnered with, guides you through the process of making or updating a legally valid will and including a gift to OCRA. The entire process takes less than 20 minutes and is 100% free. This is an easy way to help patients and support survivors well into the future.

FreeWill can also help you easily plan beneficiaries for your non-probate assets (such as an IRA, 401(k), life-insurance policy, or any other assets not included in your will) in one place. You can even designate OCRA as a beneficiary of these kinds of assets if you choose.

Already made a gift to OCRA in your estate plan?

Please fill out this form to let us know so we can say thank you and update our records!

Email donations@ocrahope.org or call 212-268-1002 to notify us of your plans or for further information.

Related Topics

OCRA Invests More than $10.8 Million Toward Research, Part of $14.5 Million Commitment in 2025

OCRA Invests More than $10.8 Million Toward Research, Part of $14.5 Million Commitment in 2025

In 2025, Ovarian Cancer Research Alliance (OCRA) invested more than $10.8 million toward scientific research—part of our $14.5 million commitment to strengthen the community through research, patient support, education and advocacy. This year’s investment represents OCRA’s broadest scope to date, encompassing not only our renowned grant programs but also global collaborations leveraging artificial intelligence (AI) … Continued

Read more

The Overview: October 2025

The Overview: October 2025

KVIA-TV ABC-7 News El Paso recently featured OCRA-funded researcher Daniel Heller, PhD, and his team at Memorial Sloan Kettering Cancer Center, whose innovative work is bringing new hope for detecting ovarian cancer at its earliest stages through a simple blood test. Dr. Heller’s research lab is developing a liquid biopsy that uses nanosensors and artificial intelligence (AI) to measure multiple proteins … Continued

Read more

Stay Informed

Get email updates about research news, action alerts, and ways to join the fight.

We care about your data. Read our privacy policy.